Breaking News To Trading Moves

Moderna’s mRNA flu vaccine gets FDA adviser backing

17 min · 20. juni 2026
episode Moderna’s mRNA flu vaccine gets FDA adviser backing cover

Beskrivelse

FDA advisers backed Moderna’s mRNA flu vaccine, mFlusiva, for adults aged 50 and older. This is an important healthcare headline because it tests whether mRNA can move beyond COVID and become part of the regular seasonal vaccine market. For Moderna, the catalyst matters because the company needs new revenue streams after COVID vaccine demand slowed. The FDA decision is expected by 5 August 2026. If approved, the vaccine would support the idea that Moderna’s platform can create repeatable revenue outside pandemic products. Winners mRNA platform winners This is the clearest winning group. FDA adviser support improves confidence that mFlusiva can reach the market and gives investors another reason to believe mRNA can work in large, recurring vaccine categories. The impact is not just about one flu shot. It is about whether the market starts valuing mRNA platforms as long-term seasonal vaccine businesses. Names: $MRNA (Moderna), $BNTX (BioNTech) Pharmacy and healthcare access winners If Moderna’s flu shot is approved and adopted, pharmacies and healthcare distribution channels could benefit from another seasonal vaccine moving through the system. More vaccine options can support patient visits, pharmacy traffic, appointment activity and inventory movement during flu season. This impact would depend on adoption, pricing and how quickly healthcare providers add the product to their vaccine programmes. Names: $CVS (CVS Health), $WBA (Walgreens Boots Alliance) Healthcare distribution winners Vaccines do not just need approval. They need ordering, storage, shipping and national distribution. If mFlusiva becomes part of the US seasonal flu market, large healthcare distributors could benefit from the extra product flow. These companies may not get the same headline reaction as Moderna, but they can still be part of the second-order trading impact. Names: $MCK (McKesson), $COR (Cencora) Losers Traditional flu vaccine incumbents If Moderna’s mRNA flu vaccine is approved and gains traction, traditional flu vaccine makers could face a new competitive threat. These companies already have established flu vaccine businesses, but a successful mRNA product could raise questions about future market share, pricing power and whether older vaccine platforms look less attractive to investors. Names: $SNY (Sanofi), $GSK (GSK), $AZN (AstraZeneca) Non-mRNA vaccine technology names This group could be pressured if investors decide mRNA has a stronger long-term position in respiratory vaccines. The market may become more selective and reward companies with faster, more adaptable vaccine platforms. That can make alternative vaccine technologies face tougher comparisons, especially if mRNA products keep gaining regulatory support. Names: $NVAX (Novavax), $DVAX (Dynavax) Large pharma vaccine competitors Big pharma companies with vaccine exposure may not lose immediately, but they could face a tougher narrative if Moderna proves that mRNA can compete in seasonal flu. Investors may ask whether larger, diversified healthcare companies can defend their vaccine franchises against faster-moving biotech platforms. The impact is likely more about sentiment and future competition than immediate revenue loss. Names: $PFE (Pfizer), $JNJ (Johnson & Johnson) #StockMarket #Trading #Investing #DayTrading #SwingTrading #Moderna #BiotechStocks #HealthcareStocks #VaccineStocks #PharmaStocks #FDA #MRNA #BioNTech #FluVaccine #PharmaNews #HealthcareInvesting #StockMarketNews #TradingIdeas

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Breaking News To Trading Moves sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

561 Episoder

episode Why holding overnight is not as risky as traders think cover

Why holding overnight is not as risky as traders think

Many traders believe every position must be closed before the session ends because holding overnight automatically creates unacceptable risk. The fear usually comes from price gaps, unexpected headlines, earnings surprises or changes in global markets while the trader is asleep. Those risks are real, but the conclusion is often exaggerated. Holding overnight is not automatically reckless. What matters is position size, setup quality, liquidity, event awareness and preparation for an adverse move. Overnight risk is easier to see An overnight gap is obvious because the market may open away from the previous close. Intraday risk feels less dramatic, although sudden reversals and breaking news can strike at any time. Closing everything before the bell may avoid some gap risk, but it can create other problems: • Taking weaker trades because of pressure to make money quickly • Overtrading because every position must work within a few hours • Using tight stops that are hit by normal market noise • Missing trends that need several sessions to develop Risk does not disappear when a position is closed before the market shuts. It simply changes form. Time can improve a good setup Strong trades do not always move immediately. A breakout may need time to attract volume. A trend may pause before continuing. Forcing every idea into a single day can lead to premature exits. Holding overnight can provide exposure to multi-day momentum, breakout continuation, sector rotation, post-earnings drift and wider market trends. The advantage is giving a well-researched setup enough time while keeping risk controlled. Position size matters more than the clock A large overnight position can be dangerous. A smaller position may be manageable. Traders often focus too much on the holding period and not enough on exposure. Before holding overnight, ask: • How much could the stock realistically gap against me? • Is earnings, economic data or company news due? • Is the stock liquid enough to exit without excessive slippage? • Is my position small enough to survive an abnormal move? • Would a gap damage my account or create only a planned loss? When the size is appropriate, an overnight move does not have to threaten the account. The position should already allow for a different opening price. Not every trade belongs overnight Earnings, regulatory decisions, court rulings, clinical trial results or major economic announcements can create unusually high uncertainty. Thinly traded stocks may also gap sharply because liquidity is limited. Avoid holding when: • The original reason for entering is no longer valid • A major binary event is approaching • The position is too large for the possible gap • Liquidity is poor • The trade has become a hope-based rescue attempt The decision should come from the setup, not hope or emotional attachment. The real skill is planned exposure Risk management is not about eliminating uncertainty. It is about choosing acceptable risks and limiting the damage when the market behaves unexpectedly. Holding overnight can reduce screen time, lower the urge to overtrade and allow stronger trends to develop. The goal is not unlimited overnight exposure. It is to stop treating every overnight position as automatically irresponsible. A carefully selected trade, held at the correct size, with no major event risk and a clear exit plan, may be less dangerous than several rushed intraday trades. #StockMarket #Trading #Investing #DayTrading #SwingTrading #OvernightTrading #TradingPsychology #RiskManagement #PositionSizing #TradingDiscipline #GapRisk #TradingStrategy

16. juli 202621 min
episode The BlackRock Hegemony and the Asset Management Divide cover

The BlackRock Hegemony and the Asset Management Divide

BlackRock reported adjusted earnings of $13.91 per share, while assets under management reached a record $15.34 trillion. Clients added $192 billion of net new money, with strong demand across iShares ETFs, bonds, private credit and infrastructure. Its operating margin rose to 45.9%, and management increased planned 2026 share repurchases to $2 billion. The results show that BlackRock is benefiting from rising markets, ETF adoption and demand for private assets. Why the story matters Its growth shows that investors are still allocating money across public and private markets, although smaller managers may struggle as more capital flows towards global platforms. Winners Large diversified asset managers Names: $BLK (BlackRock), $BX (Blackstone) Reason: BlackRock is the direct winner from record assets, strong inflows, higher margins and increased share repurchases. Blackstone may benefit as investors continue allocating money to large private-market platforms with global brands and broad product ranges. Alternative asset managers Names: $KKR (KKR), $ARES (Ares Management) BlackRock’s private-market inflows indicate that demand for private credit and infrastructure remains healthy. KKR and Ares could benefit if pension funds, insurers and wealthy investors continue increasing allocations outside public stocks and bonds. Borrowers are also using private lenders when bank financing is restricted. Market infrastructure companies Names: $NDAQ (Nasdaq), $CME (CME Group) Reason: More assets flowing into ETFs can support trading activity, market data, index licensing and risk-management demand. Nasdaq benefits from exchange services and index products. CME benefits from futures and options activity across multiple asset classes. Losers Traditional active managers Names: $TROW (T. Rowe Price), $JHG (Janus Henderson) Reason: The strength of BlackRock’s iShares business highlights the continuing shift towards lower-cost ETFs and passive funds. Traditional active managers may face fee pressure and weaker flows if investors prefer index products. They must deliver stronger performance or specialised strategies to justify higher charges. Mid-sized investment managers Names: $BEN (Franklin Resources), $VCTR (Victory Capital) Reason: BlackRock can invest heavily in technology, compliance and distribution while spreading those costs across a much larger asset base. Mid-sized firms may struggle to match its pricing, brand and product range, even while the wider industry grows. Private-credit competitors Names: $OWL (Blue Owl Capital), $APO (Apollo Global Management) Reason: Blue Owl and Apollo can benefit from growing private-credit demand, but BlackRock is becoming a stronger competitor. More competition may raise fundraising costs, make attractive loans harder to secure and force managers to offer better terms. Trading takeaway The bullish interpretation is that BlackRock’s quarter confirms healthy fund flows, strong ETF demand and continued expansion in private markets. The bearish interpretation is that more industry profits may be captured by a small number of financial giants. For traders, $BLK is the main stock to watch. The reaction in $BX, $KKR, $ARES, $TROW, $BEN, $OWL and $APO may show whether investors view these results as positive for the sector or as proof that BlackRock is becoming harder to compete against. #StockMarket #Trading #Investing #DayTrading #SwingTrading #BlackRock #BLK #AssetManagement #ETFs #WallStreet #FinancialStocks #PrivateCredit #PrivateMarkets #AlternativeInvestments #MarketNews #Earnings #FundFlows

16. juli 202618 min
episode The market does not pay you more for trading more often cover

The market does not pay you more for trading more often

Many traders assume that more screen time, more setups and more trades must eventually produce more profit. It feels logical. If one good trade can make money, then ten trades should create more opportunity. But markets do not reward activity. They reward decision quality, patience, risk control and the ability to act only when the odds are genuinely favourable. This episode explores why overtrading is one of the fastest ways to damage an otherwise sensible strategy. The problem is rarely a lack of effort. In many cases, it is too much effort applied at the wrong time. More trades do not mean more opportunity The market does not pay you for activity. Some sessions offer several clean opportunities. Other sessions offer nothing worth taking. A trader who accepts this can stay selective. A trader who does not may begin forcing entries simply to feel productive. That often leads to: • Taking weaker setups outside the plan • Entering late because of fear of missing out • Increasing size after a loss • Trading during unclear conditions • Turning boredom into unnecessary risk • Paying more through spreads and slippage The more frequently you trade, the more chances you create to make emotional, technical and risk-management mistakes. Overtrading starts before the extra trade The visible problem is the unnecessary entry. The real problem often begins earlier. You may be tired, frustrated, bored or under pressure to make money. You may have missed the first move and feel desperate to catch the next one. You may have taken a loss and feel that the market owes you a recovery. These emotions quietly lower your standards. A setup you would normally reject suddenly looks acceptable because you want action. Discipline is not only about managing an open position. It is also about protecting the quality of the decision that comes before the trade. A good trader is paid for selectivity Professional thinking means accepting that not every market condition deserves participation. You may need to sit out when: • Price is moving without clear structure • Volatility is too low or too unpredictable • The risk-to-reward ratio is unattractive • Your setup is incomplete • You are trading from emotion rather than evidence • You have reached your daily loss limit Sitting out is not laziness. Cash is also a position. Preserving focus and trading capital can be more valuable than forcing another attempt. Quality should come before frequency A strong process is built around repeatable conditions. You should know what must happen before you enter, where the trade is invalidated and how much you are prepared to lose. Reducing the number of trades can help you: • Focus on higher-quality setups • Lower transaction costs • Improve emotional control • Avoid revenge trading • Protect yourself in poor conditions • Review decisions more clearly Fewer trades do not guarantee better results, but unnecessary trades almost always create unnecessary risk. #StockMarket #Trading #Investing #DayTrading #SwingTrading #TradingPsychology #RiskManagement #Overtrading #TraderMindset #TradingDiscipline #PriceAction #TechnicalAnalysis #MarketPsychology #CapitalProtection #TradingStrategy

I går18 min
episode JPMorgan posts record $21.2 billion profit cover

JPMorgan posts record $21.2 billion profit

JPMorgan Chase posted a record quarterly profit of $21.2 billion, supported by surging equity trading, stronger investment-banking fees and continued strength across its operations. Equity-trading revenue jumped 86%, while investment-banking fees rose as mergers, acquisitions, IPO activity and corporate financing recovered. The results suggest that Wall Street’s largest firms are benefiting from active markets and stronger deal flow. Not every financial company will benefit equally. Some groups are positioned to capture more fees, while others remain exposed to deposit costs, credit losses and weaker lending margins. Winners Large Investment Banks Large investment banks are clear winners because they earn revenue from advisory work, underwriting and trading. When companies announce acquisitions, issue shares, sell bonds or prepare IPOs, these banks collect fees. JPMorgan’s quarter is a positive read-through for Goldman Sachs and Morgan Stanley. Their shares could benefit if the recovery in dealmaking is sustainable. Names: JPMorgan Chase ($JPM), Goldman Sachs ($GS) and Morgan Stanley ($MS) Exchanges and market infrastructure Exchange operators benefit when volatility, trading volumes and hedging activity rise. More transactions can mean higher clearing, data and trading revenue. A stronger IPO market may support Nasdaq, while increased futures and options activity can help CME Group and Cboe. Intercontinental Exchange may benefit from greater market activity. Names: CME Group ($CME), Intercontinental Exchange ($ICE), Nasdaq ($NDAQ) and Cboe Global Markets ($CBOE) Diversified US Banks Diversified banks can benefit from improved trading, corporate activity, loan growth and fee income. Bank of America and Citigroup have large capital-markets operations, while Wells Fargo is more exposed to lending. Names: Bank of America ($BAC), Citigroup ($C) and Wells Fargo ($WFC) Losers Regional Banks Regional banks may struggle to match Wall Street giants because they have less exposure to global trading, IPOs and large mergers. Their results depend more heavily on deposit costs, loan demand and net interest margins. If investors favour fee-heavy banks, regional lenders could lag the wider financial sector. Names: KeyCorp ($KEY), Citizens Financial Group ($CFG) and Regions Financial ($RF) Consumer Credit Specialists Consumer lenders remain vulnerable to rising delinquencies, charge-offs and pressure on lower-income borrowers. Credit-card and auto-finance companies face greater risk when borrowing costs stay high. Investors will watch loan-loss provisions closely. Names: Capital One ($COF), Synchrony Financial ($SYF) and Ally Financial ($ALLY) Banks with rising costs Strong revenue does not automatically produce stronger profits. Compensation, technology, compliance and restructuring expenses can reduce the benefit of higher income. JPMorgan raised its expense outlook, showing that cost discipline remains important across the sector. Names: Citigroup ($C), Wells Fargo ($WFC) and Bank of America ($BAC) Trading Takeaway The report is broadly positive for $JPM, $GS, $MS, $CME and $ICE. It suggests that trading, investment banking and capital-markets activity remain strong. However, expectations are elevated. If bank stocks fail to rally after such impressive earnings, traders may conclude that the good news is already priced in. Watch whether strength spreads across financial stocks, whether deal activity continues and whether management teams warn about expenses, credit losses or weaker consumer demand. #StockMarket #Trading #Investing #DayTrading #SwingTrading #JPMorgan #BankStocks #WallStreet #Earnings #InvestmentBanking #FinancialSector #MarketNews #IPO #MergersAndAcquisitions #USStocks

I går22 min
episode Why Day Traders Often Overestimate Their Edge cover

Why Day Traders Often Overestimate Their Edge

Many day traders believe they have found an edge when they may be benefiting from favourable outcomes, a market environment or a sample of trades that is too small to prove anything. A few winning sessions can make a strategy feel reliable, but short-term results can be influenced by volatility, liquidity, news flow and randomness. What Does A Real Trading Edge Look Like? A trading edge is not one profitable trade, one setup or one good month. It is a repeatable advantage that produces positive results across many trades after fees, slippage and changing market conditions are included. A genuine edge should answer: • Why should this setup work? • In which conditions does it perform best? • When does it struggle? • Is the sample size large enough? • What is the average win compared with the average loss? • Are results still positive after all costs? Without clear answers, a trader may have a winning streak, but not a proven advantage. Why Small Samples Create False Confidence Ten trades can feel meaningful when real money is involved, but statistically they may reveal little. A trader can win seven out of ten through luck, while another can lose seven out of ten using a strategy that becomes profitable over a larger sample. Traders often credit winners to skill while blaming losses on bad luck or unexpected news. This makes the strategy appear stronger than the evidence suggests. The Market Can Do The Heavy Lifting Some strategies look exceptional during strong trends or high volatility, when the market regime itself is creating favourable opportunities. When conditions change: • Breakout traders may suffer in choppy markets • Mean-reversion traders can be hurt by persistent trends • Momentum traders may find fewer setups when volatility falls • Scalpers can lose their advantage when spreads increase An edge is not just a setup. It is the setup, environment, execution and risk management working together. Signs You May Be Overestimating Your Edge • Increasing size after only a few winning days • Ignoring losing trades that do not fit the strategy • Changing rules to avoid taking a loss • Believing a high win rate guarantees profitability • Failing to record fees and slippage • Assuming one market regime will continue indefinitely • Treating confidence as proof Process Matters More Than Prediction Trading is less about knowing what happens next and more about building a process that can survive uncertainty. Define entries, exits, position size, invalidation points and daily loss limits before emotions take control. Review profitable and losing trades honestly. A winning trade can still be a bad decision. A losing trade can still be correctly executed. One outcome does not prove the quality of the process. How To Test Your Edge More Honestly Track a meaningful sample. Separate results by setup, market condition, time of day and instrument. Measure expectancy rather than focusing only on win rate. Include every cost and review drawdowns. If the edge depends on instinct that cannot be explained or measured, it may be harder to verify than it appears. The Real Advantage Is Self-Awareness The market gives fast feedback, but not always accurate feedback. A win feels like proof. A loss feels personal. A streak feels permanent. Strong traders remain cautious. They respect randomness, protect capital and continue testing even when results are good. The goal is not to eliminate confidence. It is to make confidence proportional to evidence.

14. juli 202615 min